
Alliance for Patient-centred UTI Research (APUR)
The Alliance for Patient-centred UTI Research (APUR) is a collaboration between a group of mission-driven enterprises and non-profit organizations working to improve the lives of patients.
Founded by Live UTI Free (IE), Chronic UTI Australia, CUTIC (UK), and Let’s Talk UTI (US);
APUR is a global alliance focused on quality of life and access to care for people living with urinary tract infection (UTI) by advancing the understanding and management of UTI through patient-centred research and education.
Urinary tract infection (UTI) affects around 404 million people (85% female) globally every year. We intend to change that.
Collaborate With Us
APUR collaborates with organizations in the field of women’s health to improve the health and wellbeing of patients. Whether you are looking to engage our community, are seeking support for patient and public engagement, or wish to fund research that will change people’s lives, you’ve come to the right place.
Research participant recruitment, study management, patient involvement, education, and data-driven insights are our specialties, but there are many ways we can lend a helping hand.
Our alliance maintains strong connections with researchers, clinicians, and patients alike. We’re always happy to explore your interest in working with us, and look forward to hearing from you!
Get in Touch
Who We Are




Our Research
APUR’s first research collaboration was The Global UTI Project, which was conducted in 2024.
The results of this study enabled our research team to further refine the Recurrent Urinary Tract Infection Symptom Scale (RUTISS), the first fully validated patient-reported outcome measure for recurrent UTI.
Using data from our longitudinal 40-day Global UTI Project symptom tracking study, this research confirmed that the RUTISS can reliably detect changes in symptoms during treatment and establishes what a meaningful improvement looks like from the patient perspective.
The RUTISS and its accompanying quality of life measure, the Recurrent Urinary Tract Infection Impact Questionnaire (RUTIIQ), are now ready to use in clinical practice and clinical trials, putting patient voices at the center of intervention evaluation.
Read our open-access publication in the peer-reviewed journal Urology here (RUTISS) and Neurourology and Urodynamics here (RUTIIQ).
You can also read more about the RUTISS and its complementary Patient-Reported Outcome Measure (PROM), the RUTIIQ, at PAREDInsights.org.
More Research from APUR Alliance Members

- The Recurrent Urinary Tract Infection Symptom Scale: Responsiveness to Antibiotic Treatment and the Minimal Clinically Important Difference
- Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ)
- Multi-Platform analytics integration for clinical trial Recruitment: A digital health informatics implementation framework
- Psychosocial burden and healthcare disillusionment in recurrent UTI: a large-scale international survey of patient perspectives
- Public interest in online information on recurrent UTIs is greatest for information with the poorest publication quality
- Living With and Managing Uncomplicated Urinary Tract Infection: Mixed Methods Analysis of Patient Insights From Social Media
- Using the Working Model of Adjustment to Chronic Illness to explain the burden of recurrent urinary tract infection: A survey-based study
